Using serum alanine aminotransferase (S-ALAT) as a marker [34], we found evidence of a relationship between CDKN2B expression in SAT and hepatic steatosis, since S-ALAT was positively correlated with CDKN2B expression, also after BMI adjustment. Here, CDKN2B is linked to fatty liver disease.